0

Dyslipidemia Collection
 41-60 of 364 Articles
Articles |  3 August 2010
Nonoptimal Lipids Commonly Present in Young Adults and Coronary Calcium Later in Life: The CARDIA (Coronary Artery Risk Development in Young Adults) Study
Mark J. Pletcher, MD, MPH; Kirsten Bibbins-Domingo, PhD, MD; Kiang Liu, PhD; et al.
Ann Intern Med. 2010;153(3):137-146. doi:10.7326/0003-4819-153-3-201008030-00004
Articles |  3 August 2010
Weight and Metabolic Outcomes After 2 Years on a Low-Carbohydrate Versus Low-Fat Diet: A Randomized Trial
Gary D. Foster, PhD; Holly R. Wyatt, MD; James O. Hill, PhD; et al.
Ann Intern Med. 2010;153(3):147-157. doi:10.7326/0003-4819-153-3-201008030-00005
Articles |  3 August 2010
Outcome Reporting Among Drug Trials Registered in ClinicalTrials.gov
Florence T. Bourgeois, MD, MPH; Srinivas Murthy, MD; Kenneth D. Mandl, MD, MPH
Ann Intern Med. 2010;153(3):158-166. doi:10.7326/0003-4819-153-3-201008030-00006
Articles |  20 April 2010
Rosuvastatin for Primary Prevention in Older Persons With Elevated C-Reactive Protein and Low to Average Low-Density Lipoprotein Cholesterol Levels: Exploratory Analysis of a Randomized Trial
Robert J. Glynn, ScD; Wolfgang Koenig, MD; Børge G. Nordestgaard, MD; et al.
Ann Intern Med. 2010;152(8):488-496. doi:10.7326/0003-4819-152-8-201004200-00005
Editorials |  20 April 2010
Statins for Primary Prevention in Older Adults: Who Is High Risk, Who Is Old, and What Denotes Primary Prevention?
Susan J. Zieman, MD, PhD; Pamela Ouyang, MBBS
Ann Intern Med. 2010;152(8):528-530. doi:10.7326/0003-4819-152-8-201004200-00011
Articles |  19 January 2010
Optimizing Statin Treatment for Primary Prevention of Coronary Artery Disease
Rodney A. Hayward, MD; Harlan M. Krumholz, MD; Donna M. Zulman, MD; et al.
Ann Intern Med. 2010;152(2):69-77. doi:10.7326/0003-4819-152-2-201001190-00004
Reviews |  3 November 2009 FREE
Systematic Review: Comparative Effectiveness and Harms of Combination Therapy and Monotherapy for Dyslipidemia
Mukul Sharma, MD, MSc; Mohammed T. Ansari, MBBS, MMedSc, MPhil; Ahmed M. Abou-Setta, MD, PhD; et al.
Ann Intern Med. 2009;151(9):622-630. doi:10.7326/0003-4819-151-9-200911030-00144
Academia and the Profession |  18 August 2009 FREE
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and ElaborationPRISMA: Explanation and Elaboration
Alessandro Liberati, MD, DrPH; Douglas G. Altman, DSc; Jennifer Tetzlaff, BSc; et al.
Ann Intern Med. 2009;151(4):W-65-W-94. doi:10.7326/0003-4819-151-4-200908180-00136
Ideas and Opinions |  21 July 2009
Cholesterol Control Beyond the Clinic: New York City's Trans Fat Restriction
Sonia Y. Angell, MD, MPH; Lynn Dee Silver, MD, MPH; Gail P. Goldstein, MPH; et al.
Ann Intern Med. 2009;151(2):129-134. doi:10.7326/0003-4819-151-2-200907210-00010
Articles |  16 June 2009
Red Yeast Rice for Dyslipidemia in Statin-Intolerant Patients: A Randomized Trial
David J. Becker, MD; Ram Y. Gordon, MD; Steven C. Halbert, MD; et al.
Ann Intern Med. 2009;150(12):830-839. doi:10.7326/0003-4819-150-12-200906160-00006
Reviews |  16 June 2009
Narrative Review: Statin-Related Myopathy
Tisha R. Joy, MD; Robert A. Hegele, MD
Ann Intern Med. 2009;150(12):858-868. doi:10.7326/0003-4819-150-12-200906160-00009
Editorials |  16 June 2009
Balancing Randomized Trials With Anecdote
Paul S. Phillips, MD
Ann Intern Med. 2009;150(12):885-886. doi:10.7326/0003-4819-150-12-200906160-00014
Articles |  21 April 2009 FREE
Using a Drug Facts Box to Communicate Drug Benefits and Harms: Two Randomized Trials
Lisa M. Schwartz, MD, MS; Steven Woloshin, MD, MS; H. Gilbert Welch, MD, MPH
Ann Intern Med. 2009;150(8):516-527. doi:10.7326/0003-4819-150-8-200904210-00106
Editorials |  21 April 2009 FREE
Communicating Drug Benefits and Risks Effectively: There Must Be a Better Way
Jerry Avorn, MD; William H. Shrank, MD, MSHS
Ann Intern Med. 2009;150(8):563-564. doi:10.7326/0003-4819-150-8-200904210-00012
Reviews |  7 April 2009
Systematic Review: Association of Low-Density Lipoprotein Subfractions With Cardiovascular Outcomes
Stanley Ip, MD; Alice H. Lichtenstein, ScD; Mei Chung, MPH; et al.
Ann Intern Med. 2009;150(7):474-484. doi:10.7326/0003-4819-150-7-200904070-00007
Articles |  3 March 2009
Response to Newly Prescribed Lipid-Lowering Therapy in Patients With and Without HIV Infection
Michael J. Silverberg, PhD, MPH; Wendy Leyden, MPH; Leo Hurley, MPH; et al.
Ann Intern Med. 2009;150(5):301-313. doi:10.7326/0003-4819-150-5-200903030-00006
Articles |  17 February 2009
Comparing Impact and Cost-Effectiveness of Primary Prevention Strategies for Lipid-Lowering
Mark J. Pletcher, MD, MPH; Lawrence Lazar, MD; Kirsten Bibbins-Domingo, PhD, MD; et al.
Ann Intern Med. 2009;150(4):243-254. doi:10.7326/0003-4819-150-4-200902170-00005
Articles |  20 January 2009
High-Density Lipoprotein Particle Size and Concentration and Coronary Risk
Karim El Harchaoui, MD; Benoit J. Arsenault, MSc; Remco Franssen, MD; et al.
Ann Intern Med. 2009;150(2):84-93. doi:10.7326/0003-4819-150-2-200901200-00006
Articles |  6 January 2009
Association Between Statin Use and Risk for Keratinocyte Carcinoma in the Veterans Affairs Topical Tretinoin Chemoprevention Trial
David D. Dore, PharmD, PhD; Kate L. Lapane, PhD; Amal N. Trivedi, MD, MPH; et al.
Ann Intern Med. 2009;150(1):9-18. doi:10.7326/0003-4819-150-1-200901060-00004
Articles |  4 November 2008 FREE
Effects of an Oral Ghrelin Mimetic on Body Composition and Clinical Outcomes in Healthy Older Adults: A Randomized Trial
Ralf Nass, MD; Suzan S. Pezzoli, BA; Mary Clancy Oliveri, MS; et al.
Ann Intern Med. 2008;149(9):601-611. doi:10.7326/0003-4819-149-9-200811040-00003
Advertisement
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)